CSIMarket


Penumbra Inc   (PEN)
Other Ticker:  
 


 

Penumbra Inc

PEN's Financial Statements and Analysis



Penumbra Inc reported in the forth quarter of 2023 net earnings per share of $1.33 an increase by 1207.82 % year on year from $0.10 and an improvement of 479.6 % from $0.23 realized in III. Quarter (Sep 30 2023).


forth quarter of 2023
Earnings Per Share Revenues
$ 1.33 $  285 Mill
$+1.23     +1207.82 % $+63M     +28.69 %



Penumbra Inc 's Revenue rose by 28.69 % in forth quarter of 2023 (Dec 31 2023) year on year, to $285 million and advanced by 5.07 % sequentially.


Penumbra Inc is

More on PEN's Income Statement



Penumbra Inc 's net income of $54.218 million in the forth quarter of 2023 increased by 1298.45 % from net earnings of $3.877 million achieved in IV. Quarter a year ago.

Sequentially net earnings grew by 488.43 % from net income of $9.214 million realized in previous quarter.

More on PEN's Growth

Penumbra Inc Inventories
Inventories grew by 16.17 % to $388 million from IV. Quarter a year ago, sequentially inventories rose by 3.68 %. PEN's Cash flow In the forth quarter of 2023 company's net cash flow was $67 million

More on PEN's Cash flow Statement


Penumbra Inc does not pay out common stock dividend.

In trailing twelve-month period Penumbra Inc earned $ 2.48 cash per share, on a free-cash flow basis 109.85 % of net earning per share.

Book value grew by 6.82 % sequentially to $30.07 per share, 226.47% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ 24.02 per share from $ 22.05.

Company repurchased 0.02 million shares or 0.04 % in Dec 31 2023.
Interest Coverage Ratio was 16.83.

More on PEN's Dividends

 Market Capitalization (Millions) 9,066
 Shares Outstanding (Millions) 39
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) 1,059
 Net Income (TTM) (Millions $) 91
 Cash Flow (TTM) (Millions $) 98
 Capital Exp. (TTM) (Millions $) -15
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -




Penumbra Inc does not pay out common stock dividend.

In trailing twelve-month period Penumbra Inc had $ 2.48 cash flow per share, on a free-cash flow basis 109.85 % of net earning per share.

Book value grew by 6.82 % sequentially to $30.07 per share, 226.47% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ 24.02 per share from $ 22.05.

Company repurchased 0.02 million shares or 0.04 % in Dec 31 2023.
Interest Coverage Ratio was 16.83.

More on PEN's Balance Sheets

 Market Capitalization (Millions) 9,066
 Shares Outstanding (Millions) 39
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) 1,059
 Net Income (TTM) (Millions $) 91
 Cash Flow (TTM) (Millions $) 98
 Capital Exp. (TTM) (Millions $) -15
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -
   


  News about Penumbra Inc Earnings

2. Unprecedented Growth: Penumbra Inc's EPS Skyrocketed by 1207.82% in 2023, Setting a New Benchmark in the Medical Equipment & Supplies Industry



The recently released financial results of Penumbra Inc for the fiscal year ending on December 31, 2023, have revealed an impressive growth trajectory for the company. With a substantial increase in net profit per share and revenue, improved profit margins, and notable changes in inventory and accounts receivable levels, Penumbra Inc is well-positioned to navigate the competitive landscape of the Medical Equipment and Supplies industry.
I. Stellar Financial Performance:
In the Dec 31, 2023, report, Penumbra Inc showcased outstanding results. The net profit per share experienced a remarkable growth rate of 1207.82% year-on-year, reaching $1.33 per share. Moreover, the revenue witnessed a sig...

Penumbra Inc Surpasses Industry Growth with Astonishing Revenue Surge in Q3 2023

Penumbra Inc Reports Astonishing Revenue Growth and Improved Profitability in Q3 2023
Penumbra Inc, a renowned medical equipment and supplies company, recently announced its financial results for the third quarter of 2023. The company experienced a significant surge in revenue, leading to a commendable turn into profitability. With revenue growing by an impressive 26.801% to $270.95 million, Penumbra Inc showcased its strong performance in contrast to the previous financial period ending September 30, 2022, where earnings per share were at $0.23 compared to a loss of $-0.06.
In comparison to its competitors in the medical equipment and supplies industry, Penumbra Inc's revenue growth in the third qua...

Penumbra Inc Records Robust Positive Income in Q2 2023, Outperforms Medical Equipment & Supplies Industry

Penumbra Inc., a medical equipment and supplies company, has recently reported astonishing revenue growth, leading to a surge in profitability. The company's revenue grew by an impressive 25.513% to reach $261.50 million. This significant increase in revenue is accompanied by a rise in earnings per share, which reached $0.48 compared to -$0.10 in the same period the previous year.
The growth exhibited by Penumbra Inc. is particularly noteworthy, as it stands in contrast to the rest of the medical equipment and supplies industries, which experienced a decline of -0.01% in their top-line revenue. On top of that, the company's earnings per share saw an extraordinary improvement of 118.18%, rising from $0.22...

The company declared noteworthy 18.393%, revenue rise, in the first quarter of 2023 earnings season

Penumbra Inc's return on average invested assets (ROI) of 0.54% in its first quarter of 2023 is lower than the company's average ROI of 1.81%. However, the ROI has improved compared to the fourth quarter of 2022, when it w...


Date modified: 2024-02-23T13:13:41+00:00





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com